UTHR · UNITED THERAPEUTICS Corp
$499.73
-1.54 (-0.31%)
At close · Aug 14
Market Cap
$21.43B
Shares
42.89M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$2,000,000,000
as of 2026-03-31
Remaining Authorization
$500,000,000
as of 2026-06-30
Program Utilization
75.0%
$1,500,000,000 used of $2,000,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-07-30 | $1,000,000,000 | — | — | 2026-03-31 expired | 8-K , filed 2025-08-01 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $1,500,000,000 | 10-Q, filed 2026-08-05 |
| 2025-12-31 | $1,000,000,000 | 10-K, filed 2026-02-25 |
| 2024-12-31 | $1,000,000,000 | 10-K, filed 2026-02-25 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2022-12-31 | $0 | 10-K, filed 2025-02-26 |
| 2017-12-31 | $250,000,000 | 10-K, filed 2020-02-26 |
| 2016-12-31 | $500,000,000 | 10-K, filed 2019-02-27 |
| 2015-12-31 | $394,500,000 | 10-K, filed 2018-02-21 |
| 2014-12-31 | $483,100,000 | 10-K, filed 2017-02-22 |
| 2013-12-31 | $42,439,000 | 10-K, filed 2016-02-25 |
| 2012-12-31 | $188,000,000 | 10-K, filed 2015-02-24 |
| 2011-12-31 | $212,000,000 | 10-K, filed 2014-02-25 |
Key facts
CIK
1082554
CUSIP
91307C102
13F (30d)
806 filings
786 filers
Visit website
Investor relations